《儿童特应性皮炎相关食物过敏诊断与管理专家共识》解读

2021-12-30 重庆医科大学附属儿童医院重症医学科儿科药学杂志

特应性皮炎(AD)是一种儿科常见的慢性炎症瘙痒性皮肤病,与食物过敏有密切关联,临床对特应性皮炎伴发食物过敏的治疗存在许多误区,中国医师协会皮肤科医师分会儿童皮肤病专业委员会牵头制定了首个中国《儿童特应

中文标题：

发布机构：

重庆医科大学附属儿童医院重症医学科

发布日期：

2021-12-30

简要介绍：

特应性皮炎(AD)是一种儿科常见的慢性炎症瘙痒性皮肤病,与食物过敏有密切关联,临床对特应性皮炎伴发食物过敏的治疗存在许多误区,中国医师协会皮肤科医师分会儿童皮肤病专业委员会牵头制定了首个中国《儿童特应性皮炎相关食物过敏诊断与管理专家共识》,本文就该共识进行简要解读。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=a24271c00235193f, title=《儿童特应性皮炎相关食物过敏诊断与管理专家共识》解读, enTitle=, guiderFrom=儿科药学杂志, authorId=0, author=, summary=特应性皮炎(AD)是一种儿科常见的慢性炎症瘙痒性皮肤病,与食物过敏有密切关联,临床对特应性皮炎伴发食物过敏的治疗存在许多误区,中国医师协会皮肤科医师分会儿童皮肤病专业委员会牵头制定了首个中国《儿童特应, cover=https://img.medsci.cn/2022211/1644593173754_5579292.jpg, journalId=0, articlesId=null, associationId=2348, associationName=重庆医科大学附属儿童医院重症医学科, associationIntro=重庆医科大学附属儿童医院重症医学科, copyright=0, guiderPublishedTime=Thu Dec 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">特应性皮炎(AD)是一种儿科常见的慢性炎症瘙痒性皮肤病,与食物过敏有密切关联,临床对特应性皮炎伴发食物过敏的治疗存在许多误区,中国医师协会皮肤科医师分会儿童皮肤病专业委员会牵头制定了首个中国《儿童特应性皮炎相关食物过敏诊断与管理专家共识》,本文就该共识进行简要解读。 </span></p>, tagList=[TagDto(tagId=27230, tagName=皮肤疾病), TagDto(tagId=37120, tagName=儿童特应性皮炎)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=39, categoryName=皮肤性病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=19164, appHits=268, showAppHits=0, pcHits=1250, showPcHits=18894, likes=3, shares=29, comments=8, approvalStatus=1, publishedTime=Sat Feb 12 15:23:00 CST 2022, publishedTimeString=2021-12-30, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Feb 11 23:28:48 CST 2022, updatedBy=5562651, updatedName=风清月, updatedTime=Wed Jan 03 12:28:27 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=《儿童特应性皮炎相关食物过敏诊断与管理专家共识》解读.pdf)])

《儿童特应性皮炎相关食物过敏诊断与管理专家共识》解读.pdf

下载请点击：

评论区 (6)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1200311, encodeId=6640120031134, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62ef6540086, createdName=ms1000002005689709, createdTime=Mon Mar 07 19:25:34 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198458, encodeId=75cb1198458d6, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61396530261, createdName=ms8000000101171505, createdTime=Tue Mar 01 20:34:34 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196864, encodeId=06791196864e8, content=想到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Thu Feb 24 16:27:48 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196272, encodeId=db8311962e2ff, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc746428983, createdName=ms7000001680568286, createdTime=Tue Feb 22 23:57:44 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196241, encodeId=be6f1196241c7, content=又学到了一个共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88753940865, createdName=138f85e6m07暂无昵称, createdTime=Tue Feb 22 21:51:45 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
2022-03-07 ms1000002005689709

学到了

0 0
[GetPortalCommentsPageByObjectIdResponse(id=1200311, encodeId=6640120031134, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62ef6540086, createdName=ms1000002005689709, createdTime=Mon Mar 07 19:25:34 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198458, encodeId=75cb1198458d6, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61396530261, createdName=ms8000000101171505, createdTime=Tue Mar 01 20:34:34 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196864, encodeId=06791196864e8, content=想到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Thu Feb 24 16:27:48 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196272, encodeId=db8311962e2ff, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc746428983, createdName=ms7000001680568286, createdTime=Tue Feb 22 23:57:44 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196241, encodeId=be6f1196241c7, content=又学到了一个共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88753940865, createdName=138f85e6m07暂无昵称, createdTime=Tue Feb 22 21:51:45 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
2022-03-01 ms8000000101171505

学到了

102 0
[GetPortalCommentsPageByObjectIdResponse(id=1200311, encodeId=6640120031134, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62ef6540086, createdName=ms1000002005689709, createdTime=Mon Mar 07 19:25:34 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198458, encodeId=75cb1198458d6, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61396530261, createdName=ms8000000101171505, createdTime=Tue Mar 01 20:34:34 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196864, encodeId=06791196864e8, content=想到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Thu Feb 24 16:27:48 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196272, encodeId=db8311962e2ff, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc746428983, createdName=ms7000001680568286, createdTime=Tue Feb 22 23:57:44 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196241, encodeId=be6f1196241c7, content=又学到了一个共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88753940865, createdName=138f85e6m07暂无昵称, createdTime=Tue Feb 22 21:51:45 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
2022-02-24 智慧药

想到了

93 0
[GetPortalCommentsPageByObjectIdResponse(id=1200311, encodeId=6640120031134, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62ef6540086, createdName=ms1000002005689709, createdTime=Mon Mar 07 19:25:34 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198458, encodeId=75cb1198458d6, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61396530261, createdName=ms8000000101171505, createdTime=Tue Mar 01 20:34:34 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196864, encodeId=06791196864e8, content=想到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Thu Feb 24 16:27:48 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196272, encodeId=db8311962e2ff, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc746428983, createdName=ms7000001680568286, createdTime=Tue Feb 22 23:57:44 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196241, encodeId=be6f1196241c7, content=又学到了一个共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88753940865, createdName=138f85e6m07暂无昵称, createdTime=Tue Feb 22 21:51:45 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
2022-02-22 ms7000001680568286

学到了

110 0
[GetPortalCommentsPageByObjectIdResponse(id=1200311, encodeId=6640120031134, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62ef6540086, createdName=ms1000002005689709, createdTime=Mon Mar 07 19:25:34 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198458, encodeId=75cb1198458d6, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61396530261, createdName=ms8000000101171505, createdTime=Tue Mar 01 20:34:34 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196864, encodeId=06791196864e8, content=想到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Thu Feb 24 16:27:48 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196272, encodeId=db8311962e2ff, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc746428983, createdName=ms7000001680568286, createdTime=Tue Feb 22 23:57:44 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196241, encodeId=be6f1196241c7, content=又学到了一个共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88753940865, createdName=138f85e6m07暂无昵称, createdTime=Tue Feb 22 21:51:45 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
2022-02-22 138f85e6m07暂无昵称

又学到了一个共识

100 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

风湿免疫指南

《儿童特应性皮炎相关食物过敏诊断与管理专家共识》解读

相关指南

科室

工具

服务